A randomized, controlled, multicentre clinical study of optimizing Yantiao prescription in the treatment of septic shock
Phase 1
Recruiting
- Conditions
- Septic shock
- Registration Number
- ITMCTR2100004495
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients aged 18-80 years old;
2. Patients with septic shock;
3. Patients with acute attack within 3 days.
Exclusion Criteria
1. Patients with allergic constitution or allergic to known components of the drug;
2. Mental patients;
3. Subjects with intestinal obstruction caused by other causes;
4. Patients with malignant tumor;
5. The subjects who did not meet the inclusion criteria, did not use drugs according to the regulations, could not determine the efficacy or incomplete information, which affected the efficacy or safety judgment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative survival at day 28;
- Secondary Outcome Measures
Name Time Method Tumor necrosis factor-a;interleukin-6;TCM syndrome scores;Alanine transaminase;C-reactive protein;procalcitonin;echocardiography;Interleukin-8;cholinesterase;APACHE II score;Venous ultrasound of lower extremity;blood lactate;total bilirubin;SOFA score;Blood routine examination;